News Search Results
Jul 07, 2025, 02:00 ET Компания Seegene запускает STAgora™, новую платформу для анализа инфекционных заболеваний
связанного с синдромным подходом к ПЦР-тестированию в реальном времени. Этот опыт был особенно важен во время пандемии COVID-19, когда компания Seegene поставила свыше 340 миллионов тестов на COVID-19 более чем в 100 стран мира. Основной особенностью технологии синдромной диагностики в режиме реального времени
More news about: Seegene Inc.
Jul 06, 2025, 22:00 ET Seegene Luncurkan STAgora™, Platform Baru untuk Menganalisis Penyakit Menular
teknologi PCR seketika (real-time) selama lebih dari 20 tahun. Pengalaman Seegene terbukti ketika pandemi Covid-19 terjadi. Saat itu, Seegene menyediakan lebih dari 340 juta alat tes Covid-19 untuk lebih dari 100 negara di seluruh dunia. Teknologi PCR Seegene mampu memeriksa 14 patogen yang menyebabkan
More news about: Seegene Inc.
Jul 04, 2025, 14:00 ET Nasal COVID Vax Shows Promise in Phase 1 Clinical Trial
CINCINNATI, July 4, 2025 /PRNewswire/ -- During the COVID-19 pandemic, scientists learned that the critical path to infection started with the SARS-CoV-2 virus invading the nasal tissues of its victims, then
More news about: Cincinnati Children's Hospital Medical Center
Jul 04, 2025, 07:24 ET PETRO-VICTORY ENERGY CORP. AND AZEVEDO & TRAVASSOS ENERGIA S.A. SIGN BINDING MEMORANDUM OF UNDERSTANDING
the reais); changes in national and local government, legislation, taxation, controls, regulations and political or economic developments; the impact of COVID-19 or other viruses and diseases on the ability to operate; risks and hazards associated with the business; litigation; competition; the failure to meet
More news about: Petro-Victory Energy Corp.
Jul 04, 2025, 04:57 ET 2025雲頂新耀mRNA創新技術平台研發日：「雙輪驅動」升級，自研AI+mRNA平台新突破，驅動價值增長
表達水平，為mRNA腫瘤疫苗的開發奠定了堅實基礎。 雲頂新耀的mRNA平台已在新冠疫苗的開發中得到臨床驗證，其研發的PTX-COVID19-B疫苗在與輝瑞/BioNTech的Comirnaty疫苗頭對頭的全球II期臨床研究中，在免疫原性方面，接種兩劑PTX-COVID19-B疫苗的374例受試者中，2周後產生的中和抗體滴度GMT與Comirnaty相比達到統計學非劣效；此外PTX-COVID19-B總體耐受性良好，安全性和耐受性與Comirnaty相似。 我們已與全球Top 20藥企廣泛建立接洽，BD策略聚
More news about: 雲頂新耀
Jul 03, 2025, 12:38 ET BCC Research Releases 2024 Medical Devices Market Research Review
the Global Medical Device Industry: A Comprehensive Analysis of Market Trends, Technological Advancements, and Emerging Opportunities in the Post-COVID-19 Era" BOSTON, July
More news about: BCC Research LLC
Jul 03, 2025, 09:04 ET BTQ Appoints Dr. Sean Kwak, Korea's Foremost Expert in Applied Quantum Technology, as Strategic Advisor to Accelerate Global Commercialization
conditions in the financial markets; changes in laws (including regulations respecting blockchains); risks related to the direct and indirect impact of COVID-19 including, but not limited to, its impact on general economic conditions, the ability to obtain financing as required, and causing potential delays
More news about: BTQ Technologies Corp.
Jul 03, 2025, 08:00 ET Fresenius Medical Care Collaborates with Coordination of National Institutes of Health and Specialty Hospital to Extend Access to Innovative Dialysis Therapy in Mexico
including, but not limited to, changes in business, economic and competitive conditions, legal changes, regulatory approvals, impacts related to the COVID-19 pandemic results of clinical studies, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability
More news about: Fresenius Medical Care Holdings, Inc.
Jul 02, 2025, 19:22 ET Stellus Private Credit BDC Announces $0.38 Third Quarter 2025 Regular Dividend, Payable Monthly in Increments of $0.1266 in July, August, and September 2025
performance or financial condition. Statements other than statements of historical facts included in this press release, including statements about COVID-19 and its impacts, may constitute forward-looking statements and are not guarantees of future performance or results and involve a number of assumptions,
More news about: Stellus Private Credit BDC
Jul 02, 2025, 12:30 ET CEO Confidence Continues to Cool in Q2 2025 as Hiring Plans Hit an All-Time Low
CEOs expect to decrease the size of their workforce over the next 12 months. While in line with Q1 2025, this level has only been seen during the COVID-19 pandemic and in recessions.Despite the pause, tariffs remain a significant challenge for CEOs. More than
More news about: Vistage Worldwide, Inc.
Jul 02, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Petco Health and Wellness Company, Inc. and Certain Officers - WOOF
in period-over-period net sales from physical locations and digital sites that have been open for the applicable period. In the wake of the COVID-19 pandemic, Petco consistently touted the benefits of pandemic-related tailwinds on its growth and profitability, including comparable sales growth,
More news about: Pomerantz LLP
Jul 02, 2025, 09:39 ET Hawkins Way Capital Acquires Former IHG Hotel to Expand NYC Portfolio
"This acquisition reflects Hawkins Way's focus on investing in out-of-favor assets feeling post COVID-19 effects with strong potential," said Joshua Bird, Partner at Hawkins Way Capital. "Located in the heart of Manhattan's
More news about: Hawkins Way Capital
Jul 02, 2025, 09:00 ET Aqueous Health Makes Strategic Investment in Principle Diagnostics to Form a Leading Diagnostic Services and Solutions Company
Aqueous Health is uniquely positioned to capitalize on the decentralized diagnostic testing market opportunity that was accelerated by the COVID 19 pandemic. Our combined team is confident that we will build an industry leader in diagnostics services and solutions." Eckert added, "early
More news about: Aqueous Health
Jul 02, 2025, 08:43 ET StartupScience.io Acquires Startup Stack to Expand Support for Early-Stage Founders
a free resource, now with expanded reach, new exclusive deals, and deep integration into the StartupScience.io platform. Founded during the COVID-19 pandemic, Startup Stack emerged as a free and much-needed support tool during a turbulent time. Its organic growth since then has cemented its status
More news about: StartupScience.io
Jul 02, 2025, 07:00 ET CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR
FDA Emergency Use Authorization in the United States for use in adult critically ill COVID-19 patients with impending or confirmed respiratory failure. CytoSorb is not yet approved or cleared in the United States. In the U.S. and
More news about: Cytosorbents Corp
Jul 01, 2025, 14:19 ET FOX NEWS CHANNEL CLOSES IN ON BROADCAST NETWORKS WITH WINS OVER CBS, ABC AND NBC IN SECOND QUARTER
The quarter marked FNC's second highest-rated second quarter in network history with weekday total day viewers, behind only 2020's coverage of the COVID-19 pandemic. In total day, FNC saw 1.8 million viewers and 223,000 in the 25-54 demo, finishing with its top 10 highest quarter ratings of all time.
More news about: Fox News Network, LLC
Jul 01, 2025, 13:02 ET Improved Pharma initiates research and development program
degradation, and enhance the solubility and bioavailability of poorly soluble drugs. The most well-known SLN formulations include the Moderna and Pfizer COVID-19 vaccines. However, there is little consensus on the structure of SLNs with published depictions varying greatly. Understanding the structure is crucial
More news about: Improved Pharma
Jul 01, 2025, 12:00 ET RedHill Biopharma Announces Recruitment Initiated into Expanded Phase 2 Opaganib/Darolutamide Combination Study in Advanced Prostate Cancer
including several cancers, diabetes and obesity-related disorders, gastrointestinal acute radiation syndrome (GI-ARS), chemical exposure indications, COVID-19, Ebola and other viruses as part of pandemic preparedness. Opaganib's host-directed action is thought to work through the inhibition of multiple
More news about: RedHill Biopharma Ltd.
Jul 01, 2025, 10:49 ET Seegene Launches STAgora™, a New Platform for Infectious Disease Analytics
and business related to syndromic real-time PCR technologies. This expertise was particularly highlighted during the COVID-19 pandemic when Seegene provided over 340 million COVID-19 tests to more than 100 countries worldwide. The core feature of Seegene's syndromic real-time PCR technology is the ability
More news about: Seegene Inc.
Jul 01, 2025, 10:13 ET WMS: TAKING A CRUISE THIS SUMMER? DON'T FORGET TO PACK YOUR CONNECTIVITY!
Mr. Arora served as Chief Operating Officer. He stabilized and grew the WMS business over the years, notably managing it through the unprecedented Covid-19 pandemic shutdown of the cruise industry in 2020. In 2022, Mr. Arora successfully led a private equity-supported buyout of WMS to spin-off the entity
More news about: WMS
Jul 01, 2025, 10:00 ET Seegene Launches STAgora™, a New Platform for Infectious Disease Analytics
and business related to syndromic real-time PCR technologies. This expertise was particularly highlighted during the COVID-19 pandemic when Seegene provided over 340 million COVID-19 tests to more than 100 countries worldwide. The core feature of Seegene's syndromic real-time PCR technology is the ability
More news about: Seegene Inc.
Jul 01, 2025, 08:30 ET Former Moderna Chief Development Officer Melanie Ivarsson OBE Joins PhaseV's Scientific Advisory Board
at Moderna, where she was honored as an Officer of the Order of the British Empire (OBE) for her leadership in the development of one of the first COVID-19 vaccinations.
More news about: PhaseV
Jul 01, 2025, 08:30 ET PhaseV Announces New ClinOps AI Platform: Transforming Clinical Trial Operations with Precision-Guided Site Selection
Officer at Moderna, to PhaseV's advisory board. Her extensive pharmaceutical expertise, including leading the development of one of the world's first COVID-19 vaccinations, will be instrumental in driving the platform's technological development and market adoption. "By integrating causal
More news about: PhaseV
Jul 01, 2025, 08:30 ET SILICOM'S SECOND QUARTER 2025 RESULTS RELEASE SCHEDULED FOR JULY 31, 2025
Huthis in the Red Sea, rising inflation, rising interest rates and volatile exchange rates, as well as any continuing or new effects resulting from the COVID-19 pandemic, and the global economic uncertainty, which may impact customer demand by encouraging them to exercise greater caution and selectivity with
More news about: Silicom Ltd.
Jul 01, 2025, 07:30 ET Soligenix Announces Synthetic Hypericin Successfully Manufactured at Sterling Pharma Solutions
candidate, as well as our vaccine programs targeting filoviruses (such as Marburg and Ebola) and CiVax™, our vaccine candidate for the prevention of COVID-19 (caused by SARS-CoV-2). The development of our vaccine programs incorporates the use of our proprietary heat stabilization platform technology, known
More news about: SOLIGENIX, INC.